Direct Comparison of 4 Years' Drug Survival of Adalimumab, Etanercept and Infliximab in Rheumatoid Arthritis Patients. An Observational Study From the DANBIO Registry.

M.L. Hetland, I.J. Christensen, U. Tarp, L. Dreyer, A. Hansen, I.T. Hansen, G. Kollerup, L. Linde, Hanne Merete Lindegaard, U.E. Poulsen, A. Schlemmer, D.V. Jensen, S. Jensen, M. Østergaard

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2009
StatusUdgivet - 2009
Begivenhed2009 Annual Scientific Meeting. - Philadelphia, Pennsylvania, USA
Varighed: 16. okt. 200921. okt. 2009

Konference

Konference2009 Annual Scientific Meeting.
LandUSA
ByPhiladelphia, Pennsylvania
Periode16/10/200921/10/2009

Bibliografisk note

Udgivelsesdato: October 2009
Volume: 60

Citationsformater

Hetland, M. L., Christensen, I. J., Tarp, U., Dreyer, L., Hansen, A., Hansen, I. T., Kollerup, G., Linde, L., Lindegaard, H. M., Poulsen, U. E., Schlemmer, A., Jensen, D. V., Jensen, S., & Østergaard, M. (2009). Direct Comparison of 4 Years' Drug Survival of Adalimumab, Etanercept and Infliximab in Rheumatoid Arthritis Patients. An Observational Study From the DANBIO Registry.. Poster session præsenteret på 2009 Annual Scientific Meeting., Philadelphia, Pennsylvania, USA.